Tag Archives: Blood’s

Global Blood’s sickle cell drug wins FDA approval, joining Novartis’ Adakveo

Dive Brief: The Food and Drug Administration on Monday approved Global Blood Therapeutics’ sickle cell drug voxelotor, completing a rapid review that took the regulator about 90 days. The accelerated OK is conditional on the biotech completing a study to confirm the rise in hemoglobin measured in trials so far yields clinical benefit. Global Blood… Read More »